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Sphingolipids are major components of cellular membranes, and at steady-
state level, their metabolic fluxes are tightly controlled. On challenge by external
signals, they undergo rapid turnover, which substantially affects the biophysical
properties of membrane lipid and protein compartments and, consequently, signaling
and morphodynamics. In T cells, external cues translate into formation of
membrane microdomains where proximal signaling platforms essential for metabolic
reprograming and cytoskeletal reorganization are organized. This review will focus on
sphingomyelinases, which mediate sphingomyelin breakdown and ensuing ceramide
release that have been implicated in T-cell viability and function. Acting at the
sphingomyelin pool at the extrafacial or cytosolic leaflet of cellular membranes, acid and
neutral sphingomyelinases organize ceramide-enriched membrane microdomains that
regulate T-cell homeostatic activity and, upon stimulation, compartmentalize receptors,
membrane proximal signaling complexes, and cytoskeletal dynamics as essential for
initiating T-cell motility and interaction with endothelia and antigen-presenting cells.
Prominent examples to be discussed in this review include death receptor family
members, integrins, CD3, and CD28 and their associated signalosomes. Progress made
with regard to experimental tools has greatly aided our understanding of the role of
bioactive sphingolipids in T-cell biology at a molecular level and of targets explored by a
model pathogen (measles virus) to specifically interfere with their physiological activity.
Keywords: T cell, sphingomyelinase, activation, motility, measles virus
INTRODUCTION
Sphingolipids are abundant components of cellular membranes, and therefore, they effectively
take part in cellular processes requiring membrane integrity and dynamics under rheostat and
stimulated conditions (Airola and Hannun, 2013; Harayama and Riezman, 2018). Biosynthesis
and metabolism of this particular class of membrane lipids are highly complex and subject to
regulation by a variety of enzymes, and, except for initiation of synthesis and final hydrolysis
of sphingosine-1-phosphate (S1P) into hexadecenal and phosphoethanolamine, reactions in this
pathway are reversible. Thereby, many species of sphingolipids are generated that, in addition,
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vary in chain length, saturation, hydroxylation, and more or less
complex head groups, altogether defining sphingolipid diversity
(Hannun and Obeid, 2008; Gault et al., 2010; Feng et al., 2018)
(Figure 1). Further expanding the complexity of the system,
enzymes involved in sphingolipid metabolism may come in
several isoforms differing in subcellular topology and cell type-
specific expression levels (Clarke et al., 2006; Gault et al., 2010;
Airola and Hannun, 2013). Therefore, biological outcomes of
sphingolipid dynamics expectedly substantially differ.
Because of the high abundance of sphingolipid species, their
composition within the plasma and organelle membranes and
the dynamic alterations substantially impact on membrane
biophysics. In context with other membrane lipids such as
cholesterol, sphingolipids (also dependent on their acyl chain
lengths) regulate membrane fluidity, which is important for
membrane deformability during inward/outward vesiculation
and also endo/exocytosis (Hannun and Obeid, 2008; Feng
et al., 2018). In addition, membrane proteins and associated
membrane proximal signaling components compartmentalize
within membrane domains formed at steady-state conditions or
in response to stimulation or metabolic signals. Classically,
these were termed “lipid rafts” and/or—experimentally
defined—detergent-resistant membrane (DRM) domains with
sphingomyelin, glycosphingolipids, and cholesterol as major
components (Simons and Gerl, 2010; Nakayama et al., 2018).
Their composition can be dynamically altered upon signals, for
instance, provided by sensing of intracellular stress or receptor
ligation. Although as for most microdomains their exact lipid
composition is still not clear (Harayama and Riezman, 2018),
formation of ceramide-enriched membrane domains in the
anticytosolic (extrafacial) membrane leaflet has been intensively
studied. These are generated as a result of sphingomyelin
breakdown by acid sphingomyelinase (ASM), which results
in local release of ceramide (thereby eventually displacing
cholesterol) that subsequently condense into ceramide-enriched
domains that serve as platforms for signal relay and initiation,
which often directly involves regulation of membrane proximal
cytoskeletal dynamics (Gulbins et al., 2004; Bollinger et al., 2005;
Gombos et al., 2006; Adada et al., 2013; Schneider-Schaulies
and Schneider-Schaulies, 2013; Avota and Schneider-Schaulies,
2014). Ceramide-enriched membrane microdomains can be
visualized using specific antibodies and, more recently, by
redistribution of functionalized ceramide analogs also in T cells
(Collenburg et al., 2016; Walter et al., 2016). On these, sizes and
distribution of ceramide clusters under steady-state conditions
and after application of exogenous bacterial sphingomyelinase
were determined by dSTORM technology (Burgert et al.,
2017). Bioactive sphingolipids, i.e., mainly ceramide, ceramide-
1-phosphate (C1P), sphingosine, and S1P act as signaling
molecules themselves, and therefore, dynamic alterations of
this pool directly regulate many cellular responses ranging
from development and expansion to autophagy and apoptosis
(Hannun and Obeid, 2008).
In common to that of other cell types, metabolism of
membrane lipids also plays a key role in T cells as excellently
reviewed (Wu et al., 2015, 2016; Howie et al., 2017). This
review will focus on the role of sphingomyelin breakdown
and subsequent ceramide release in various aspects of T-cell
biology. Given the impact of this pathway on membrane and
cytoskeletal dynamics and signaling in these highly motile cells,
the activity of which relies on efficient propagation of external
cues, this is particularly important. Rather than discussing the
role of the bioactive sphingolipids themselves, this review aims
at integrating the two most prominent, best-studied enzymes
catalyzing sphingomyelin breakdown at the anticytosolic or
cytosolic leaflet of the T-cell plasma membrane, the ASM and
neutral (NSM2) sphingomyelinase.1
ACID AND NEUTRAL
SPHINGOMYELINASES
Isoforms of the ASM (encoded by the gene SMPD1) are
secreted (sASM) or endolysosomal ASM, where its association
to the anticytosolic membrane leaflet is required to protect
the enzyme from degradation (Goni and Alonso, 2002).
ASM activation is triggered by a variety of stimuli including
cytokines, engagement of death receptors, or, as particularly
relevant for this review, CD28. Receptor signaling-induced ASM
activation can occur intracellularly after receptor signalosome
fusion with endolysosomes (TNFR) or extracellularly after the
enzyme is translocated from the internal storage compartment
to the extrafacial leaflet of the plasma membrane (CD95)
(Gulbins and Kolesnick, 2003; Henry et al., 2013) (Figure 2).
There, ceramide release as a consequence of sphingomyelin
hydrolysis promotes formation of ceramide-enriched membrane
microdomains promoting formation and stabilization of receptor
and signalosome complexes (Gulbins et al., 2004; Bollinger
et al., 2005). At a biochemical level, ASM activation involves
phosphorylation and proteolytic processing (Figure 2) (Henry
et al., 2013). In addition to its role in cell activation,
differentiation, and apoptosis, ASM has great importance for
sphingolipid homeostasis as reflected by the development
of severe, often fatal sphingolipidoses upon genetic ASM
deficiency in mice and humans, where it is called Niemann–
Pick disease (Horinouchi et al., 1995; Smith and Schuchman,
2008; Schuchman and Desnick, 2017). Though healthy at birth,
ASM-deficient mice come down due to a progressive lysosomal
sphingolipid storage as indicated by an increasing amount of
foam cells in the bone marrow with age, extending to all
visceral organs (Kuemmel et al., 1997). Activity of the ASM
in the T-cell compartment has been clearly revealed where,
and not surprisingly, ASM deficiency correlated with elevated
levels of sphingomyelin (Boucher et al., 1995; Horinouchi et al.,
1995; Herz et al., 2009; Tischner et al., 2011; Beyersdorf and
Muller, 2015; Hollmann et al., 2016). ASM has been found
to be particularly important in CD4+ regulatory T-cell (Treg)
frequency and function in mice, indicating that the enzyme
impacts on the composition of the T-cell compartment under
homeostatic conditions (Hollmann et al., 2016; Zhou et al., 2016).
1ASM and NSM2 in humans, Asm and Nsm2 in mice. As some studies cited
investigated both human and mouse cells, we will use the nomenclature ‘ASM’ and
‘NSM2’ to facilitate reading.
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An outer membrane-resident ASM-like enzyme, SMPDL3B, was
identified in macrophages, where it reduced Toll-like receptor
(TLR) responsiveness (Heinz et al., 2015). Though it may also
be expressed in T cells, its function there is as yet unknown.
Assuming it acts as a bona fide sphingomyelinase, it appears
to do so at neutral rather than acidic pH (Heinz et al., 2015;
Gorelik et al., 2016a,b) and could thereby be considered as neutral
rather than ASM.
The best-studied member of neutral sphingomyelinases,
NSM2 (SMPD3-encoded), is ubiquitously expressed and most
abundant in the brain (from where it was initially purified) but
also in lymphatic tissues (Liu et al., 1998). It is associated with
cytosolic membrane leaflets of many compartments, including
the plasma, Golgi, and endolysosomal and nuclear membranes
(Stoffel et al., 2005; Albi et al., 2008; Cascianelli et al., 2008; Clarke
et al., 2008; Trajkovic et al., 2008; Milhas et al., 2010b; Lucki
and Sewer, 2012 Airola and Hannun, 2013; Stoffel et al., 2016)
(Figure 2). Despite that its substrate is much less abundant at the
cytosolic membrane leaflets, NSM2 is important in sphingolipid
homeostasis, because in the absence of its activity, ceramide
levels are up to 50% reduced (Marchesini et al., 2003; Stoffel
et al., 2016). NSM2 is activated in response to stress signals
and ligation of receptors such as TNFR1, CD95, CD40, and, as
particularly relevant here, CD3 (Tonnetti et al., 1999; Clarke et al.,
2006; Wu et al., 2010; Airola and Hannun, 2013; Shamseddine
et al., 2015; Bortlein et al., 2018) (Figure 2). Shuttling between
compartments and recruitment into receptor signalosomes are
important in NSM2 activation (Clarke et al., 2008; Philipp
et al., 2010). Its amino-terminal (NTD) hydrophobic domain
marked by two conserved hydrophobic segments (HS1 and HS2)
associates with, but does not span, the membrane; is separated
from the cytosolic C-terminal catalytic domain (CAT) by a
juxtamembrane domain, which interacts with the CAT domain
upon phosphatidylserine (PS) binding to the NTD domain; and
promotes a conformational switch needed for NSM2 activation
(Figure 2) (Airola and Hannun, 2013; Airola et al., 2017).
The extended CAT domain bears phosphorylation sites and a
calcineurin interaction site that possibly regulate NSM2 activity
and stability in vivo (Filosto et al., 2010, 2012; Shamseddine et al.,
2015; Airola et al., 2017) (Figure 2).
Mice deficient for NSM2 activity due to the fragilis ossium
(fro) mutation within Smpd3 (Smpd3fro/fro) or genetic knockout
(Smpd3-KO) reveal high embryonic lethality and, postnatally,
severely impaired bone and tooth mineralization, skeletal
deformation, and dwarfism, highlighting the importance of
this enzyme as critical regulator of tissue development and
homeostasis (Guenet et al., 1981; Aubin et al., 2005; Stoffel et al.,
2005; Alebrahim et al., 2014). Limited availability of NSM2-
deficient animals has as yet precluded studies on the impact of
NSM2 deficiency on the lympho/monocytic compartment under
homeostatic or infection conditions. Notably, mitochondrial
ATP release has been shown to be regulated upon NSM2-
driven ceramide generation, indicating that this enzyme takes
part in metabolic homeostasis in astrocytes (Kong et al., 2018).
If also applying to T cells, NSM2 activity could significantly
impact on the kinetics and sustainment of T-cell activation and
effector functions.
ACTIVATION OF ASM AND NSM2 IN T
CELLS
Though their impact on T-cell viability, expansion, and function
has been extensively studied (see below), the molecular basis
of ASM/NSM activation in these cells remains anecdotal. Non-
overlapping motifs were identified in the cytosolic domains of
TNFR and CD95, which independently regulate activation of
ASM and NSM2. For the latter, this involves plasma membrane
recruitment of nuclear EED/WAIT that bridges interacting
NSM2 to the receptor-associated FAN (factor associated with
NSM)/RACK1 complex also in Jurkat T cells (Philipp et al., 2010).
Ligation of CD3 and CD28 is known to activate NSM2 and ASM,
respectively (Boucher et al., 1995; Tonnetti et al., 1999; Mueller
et al., 2014; Bortlein et al., 2018), but the underlying mechanisms
are as yet unknown. In addition to its extensively studied role
in NFAT activation in costimulated T cells, early recruitment of
calcineurin to the T-cell receptor (TCR) complex was recently
reported, where it took part in Lck activation, and it is tempting
to speculate that NSM2, harboring a calcineurin interaction
site, would be corecruited with calcineurin upon CD3 ligation
(Filosto et al., 2010; Dutta et al., 2017). Cross-regulation of
sphingomyelinases has also been observed. Thus, ASM elevation
at both protein and activity levels was found enhanced in NSM2-
deficient fibroblasts, but not T cells (Qin and Dawson, 2012;
Mueller et al., 2014). Most interestingly, NSM2 activation was
retained in costimulated T cells, while that of ASM was not
(Mueller et al., 2014; Bortlein et al., 2018). Cross-regulation of
sphingomyelinases was also evidenced in T cells after surface
interaction of measles virus (MV) with an unknown receptor
on the T cells, which promoted ASM activation downstream of
NSM2 (Gassert et al., 2009; Avota et al., 2010).
IMPACT OF ASM/NSM ON T-CELL
ACTIVITY AND FUNCTION
Dynamic reorganization of both membrane domains with regard
to receptor and signalosome segregation and the cytoskeleton
is subject to regulation by sphingomyelinase activity. The very
same processes are of obvious importance in essential aspects of
T-cell activation and function such as (1) motility and homing,
(2) activation on antigen recognition in the context of organized
immunological synapses (IS) and expansion, and (3) effector
functions. The following sections will therefore review the
progress made in the understanding of ASM/NSM2 contribution
to these processes.
IMPACT OF ASM/NSM2 ACTIVITY ON
T-CELL MOTILITY AND TISSUE HOMING
T-cell migration and interaction with the endothelium during
tissue homing are governed by cell and receptor polarization
and signal relay provided by chemotactic gradients and adhesion
molecules (Ley et al., 2007; Sadik and Luster, 2012). Filopodia
formed at the leading edge of migrating T cells sense directional
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FIGURE 1 | The sphingolipid metabolic pathway. De novo synthesis of endoplasmatic reticulum (ER) ceramide is initiated (entry) by serine palmitoyl transferase
(SPT)-driven condensation of serine and palmitoyl-CoA, and further downstream activity of ceramide synthases (CerS1-6; giving rise to ceramides of different chain
lengths) and desaturase (DES). Ceramide is reversibly converted into (1) sphingomyelin by sphingomyelin synthase 1 or 2 (SMS1/2) [reversed by acid (ASM), neutral
(NSM, isoforms 1–3), or alkaline sphingomyelinases (alkSM)], (2) galactosylceramide [by galactosyltransferase (CGT) (reversed by galactosylceramidase (GALC))], (3)
C1P by ceramide kinase (CK) [reversed by ceramide-1-phosphatase (CP)], (4) glucosylceramide by glucosylceramide synthase (GCS) [reversed by
glucocerebrosidase (GBa)], or (5) sphingosine by acid or neutral ceramidase (AC, NC) (reversed by ceramide synthase, CerS). By phosphorylation, sphingosine
kinases (SK1/2) generate S1P from sphingosine (reversed by S1P phosphatase, S1PP). S1P is irreversibly degraded into hexadecenal and ethanolamine by the
activity of the S1P lyase (SPL) (exit of the sphingolipid metabolic pathway). Enzymes involved are marked in blue, and bioactive sphingolipids are highlighted in green.
FIGURE 2 | Acid and neutral sphingomyelinase 2: domains, subcellular distribution, and activation in vitro and in T cells. Schematic representation of functional
domains within the ASM [signal peptide (SP), transmembrane domain (black bar), saposin domain (SAP), proline rich domain (PL), CAT and C-terminal domain (CTD)
with glycosylation sites indicated by asterisks] and the NSM2 [hydrophobic segments 1 and 2 (HS1, HS2), juxtamembrane region (JX), and CAT, interspersed by an
insertion that bears phosphorylation and protein interaction sites (including a calcineurin binding site); palmitoylation sites are indicated by hashtags] (Goni and
Alonso, 2002; Airola and Hannun, 2013; Airola et al., 2017). The table summarized basic features of localization and activation of the enzymes and indicates
receptors known to promote ASM or NSM2 activation in T cells. §: The identity of recX activating NSM2 in T cells by MV contact is as yet unknown (Gassert et al.,
2009; Avota and Schneider-Schaulies, 2014; Mueller et al., 2014).
information, which is translated into dynamic assembly of actin
filaments pushing the leading edge forward until membrane-
tension-generated forces lead to their retraction (Bornschlogl,
2013; Leijnse et al., 2015; Leithner et al., 2016). When coupled
to adhesion to the extracellular matrix, the retrograde actin
flow generates cell movement, which is supported by stress
fiber contraction and actin disassembly in the retracting uropod
(Nordenfelt et al., 2016). On endothelial cells, T-cell rolling and
polarization are followed by activation of β2-integrins, most
prominently lymphocyte function-associated antigen 1 (LFA-1),
that switch between high- and low-affinity states (Shulman et al.,
2009; Nourshargh and Alon, 2014; Katsuno et al., 2015). T-cell
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transmigration through the endothelium relies on the interaction
of activated LFA-1 with endothelial cell intercellular adhesion
molecule 1 (ICAM-1), and integrin clusters arranged as focal
adhesions, which are linked via talin, kindlin, and vinculin
to the cytoskeleton (Moser et al., 2009; Hogg et al., 2011;
Nourshargh and Alon, 2014).
Supporting important roles of sphingomyelinases activity in
this process, ASM deficiency conferred protection against the
development of experimental autoimmune encephalitis (EAE) in
mice in which T-cell adhesion, blood–brain barrier disruption,
and intracerebral infiltration of inflammatory cells were blocked
(Becker et al., 2017). Similarly, NSM2 activity was found to
contribute to rapid homing of CD4+ T cells in vivo. When
exposed to an NSM inhibitor prior to adoptive transfer, these
accumulated to lower levels in spleen and lymph nodes than
solvent-treated control cells (Collenburg et al., 2017). Impaired
navigational capacity of leukocytes in zebrafish larvae in the
absence of FAN further supported the potential role of NSM in
cellular motility (Boecke et al., 2012).
Morphological polarization requires cytoskeletal dynamics. In
the steady state, NSM2 may negatively control actin metabolism
in T cells, because the average cell volume and frequencies of
hairy-appearing, abundant protrusions are significantly elevated
in NSM2-deficient Jurkat cells (Schoenauer et al., 2019). On
stimulation, the role of NSM2 in T-cell morphology driven by
actin reorganization may differ depending on receptor signaling:
while NSM2 ablation in primary T cells enhanced spreading
responses in response to CD3/CD28 engagement, morphological
polarization of CD4+ T cells on fibronectin-coated surfaces and
brain endothelial cells was effectively limited (Mueller et al.,
2014; Collenburg et al., 2017) (Figure 3). While ASM deficiency
did not detectably affect T-cell morphology, its hyperactivation
in response to MV caused collapse of actin-based protrusions
in ASM-sufficient cells (Gassert et al., 2009; Schoenauer et al.,
2019). This could be rescued by ablation of the ASM, but also
of the NSM2. In this particular activation system, NSM2 acts
upstream of the ASM because both genetic and pharmacologic
NSM inhibition prevent ceramide release at the cell surface
(Gassert et al., 2009). Whether sphingomyelinase-driven actin
cytoskeletal collapse observed in this system is specific for the
receptor involved, signal strength, or the cell type is currently
unknown as it has not been reported to occur upon ligation of
classical activators including TNFR1, CD95, CD3, or CD28.
Morphological polarization associated with that of receptors is
of obvious importance for spatial perception of chemoattractants.
NSM2-deficient CD4 + T cells largely failed to polarize and to
redistribute CXCR4 and thus, not surprisingly, were substantially
impaired in directional migration and velocity in response
to SDF-1α or in collagen matrices (mimicking extracellular
matrix or tissue interaction) (Collenburg et al., 2017, 2018).
Though not detectably affecting morphological polarization,
pharmacological NSM2 inhibition also ablated directionality of
human polymorphonuclear neutrophils (PMNs) in response to
formyl methionine leucyl phenylalanine (FMLP), but not their
overall motility (Sitrin et al., 2011). There, exogenous ceramide
restored chemotactic responses indicating that loss of ceramide
production due to loss of NSM2 activity causally related to
inhibition of directionality (Sitrin et al., 2011). Exogenously
added ceramides most likely incorporate into the outer leaflet,
and therefore, compensation of ceramide loss at the inner leaflet
would rely on flipping, which, at present, cannot be directly
shown in living cells. Because SDF-1α and β1-integrins do not
and FMLP is not known to activate NSM2, steady-state rather
than stimulated activity of the enzyme is apparently required for
morphological polarization of both CD4+ T cells and PMNs.
There is, so far, no evidence that sphingomyelinases contribute
to chemokine receptor or β1-integrin signaling directly, and
therefore, impaired directional motility of NSM2-deficient T
cells most likely reflects their inability to spatially perceive
exogenous signals.
Failure to perceive exogenous signals may also be of crucial
importance for explaining impaired adhesion of NSM2-deficient
cells to interferon-γ (IFN-γ)/tumor necrosis factor-α (TNF-α)-
activated endothelial cells both under static and shear stress
conditions (Collenburg et al., 2017), which, as crawling and trans-
endothelial migration (TEM), again depends on the relay of
chemokine signals promoting polarization followed by integrin
affinity maturation. In line with polarizing signals and associated
FIGURE 3 | The role of sphingomyelinases in directional sensing and translation of chemotactic and endothelial signals in T cells. Perception of chemotactic signals
through specific receptors (depicted as dashed red line) has not been found to be sensitive to ablation of NSM or ASM in T cells. Relay of these signals into
morphological front-rear and actin (shown in green) polarization as well as receptor segregation to the leading edge is sensitive to NSM ablation as, consequently,
are subsequent steps requiring directional sensing of external cues (directional migration, loose and firm adhesion, and spreading on epithelial cells as well as LFA-1
activation and clustering). In contrast, TEM of T cells relies on ASM rather than NSM activity. Notably, endothelial cell ASM is also required in this process.
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actin reorganization being a prerequisite for firm adhesion to
endothelial cells, NSM2-deficient CD4+ T cells seeded on brain
endothelial cells failed to promote formation of activated LFA-
1 clusters, which could not be stabilized by ICAM-1 clustered
on endothelial cells. Possibly, sphingomyelinase activity may also
directly impact on formation of activated LFA-1 clusters. Not
shown to apply to T cells, LFA-1 clusters were found trapped
in ceramide-enriched membrane domains on epithelial cells
(Grassme et al., 2017), and exogenously provided ASM caused
β1-integrin activation or modulated LFA-1-dependent adhesion
to ICAM-1 (Carpinteiro et al., 2016; Eich et al., 2016).
In endothelial cells, ICAM-1 clustering and cytoskeletal
anchoring as required for TEM was found to be dependent on
ASM activity, which, in contrast to that of NSM2, was also
required for transmigration in both endothelial and T cells
(Lopes Pinheiro et al., 2016; Collenburg et al., 2017). Because
NSM2 and ASM regulate cytoskeletal dynamics, their differential
roles in T-cell polarization and transmigration most likely reflect
differential cytoskeletal processes involved. Thus, pushing forces
for scanning endothelial cells for suitable TEM spots, formation
of focal adhesions and uropod contraction driven by microtubule
depolymerization and increased RhoA/ROCK activity (Takesono
et al., 2010) may be promoted by ASM activity (Chang et al.,
2008; Stroka et al., 2013), while acquisition of a migratory, highly
polarized lamellipodia/uropod-based phenotype in T cells rather
relies on NSM2 activity (Figure 3).
SPHINGOMYELINASES IN TCR
SIGNALING, COSTIMULATION, AND
EXPANSION
Immunological synapses formation requires attachment
of scanning T cells followed by spreading to allow for
functional organization of the antigen-presenting cell
(APC)/T-cell interface. As detailed above, NSM2 supported
T-cell attachment to endothelia, and it is unknown as yet
whether it also takes part in mediating or stabilizing APC/T-
cell conjugate formation. The latter has been found to be
unstable when T cells were exposed to MV prior to dendritic
cell (DC) conjugation (Shishkova et al., 2007), and though
not experimentally addressed in this study, NSM2/ASM-
mediated paralysis of the actin cytoskeleton might contribute
to IS destabilization. Surface-bound chemokines are also
important in capturing and priming T cells for synapse
formation (Friedman et al., 2006), which, as described
above, might be less efficient for NSM2-deficient cells.
Conceivably, timing and magnitude of sphingomyelinase
activation might define to what extent these enzymes take part in
conjugate formation.
Much more is known about their role in the efficiency of
T-cell activation. As for other cell types, ceramide release in
response to death receptor ligation induces apoptosis in T cells
(Andrieu-Abadie and Levade, 2002; Grassme et al., 2003; Detre
et al., 2006; Edelmann et al., 2011), and especially for that of
CD95, this contributes to activation-induced cell death and,
thereby, homeostasis of the T-cell compartment. TNFR1 and
CD95 ligation also inhibited mitogen-, αCD3/CD28-, or phorbol
ester/ionomycin-stimulated Ca2+ influx, NFAT activation, and
IL-2 synthesis in lymphoblasts and Jurkat cells via ASM
induction, indicating that ceramide release catalyzed through
its activity interferes with T-cell activation (Lepple-Wienhues
et al., 1999; Church et al., 2005) (Figure 4A). In line with
this hypothesis, accumulation of ceramides as measured in
CD4+ T-cell IS and non-IS membrane fractions of aging
mice correlated with decreased proliferative responses (Molano
et al., 2012). In turn, NSM2-deficient cells proved to be
hyperresponsive to αCD3/CD28 costimulation with regard to
cytoskeletal reorganization, Ca2+ mobilization, and initiation of
proliferation, and NSM2 activation at least partially accounted
for the loss of T-cell proliferation induced through MV surface
exposure (Mueller et al., 2014) (Figure 4B), altogether indicating
that sphingomyelinase-mediated ceramide release might be
inhibitory to T-cell activation, irrespective as to whether it is
generated in the extrafacial or cytosolic leaflet of the plasma
membrane. Notably, ceramide was found largely excluded from
T-cell plasma membrane domains engaged in TCR signaling
(Zech et al., 2009).
Strikingly, ligation of CD3 or CD28 by antibodies
individually was found to cause activation of NSM2 or
ASM, respectively. Interestingly, only NSM2 activation
was retained upon αCD3/CD28 coligation by antibodies,
and both NSM2 protein and ceramides accumulated in
the lamellopodial area of the IS (though excluded from its
center and the lamellum), indicating that sphingomyelin
breakdown, if spatiotemporally controlled, may indeed take part
in T-cell activation (Boucher et al., 1995; Tonnetti et al., 1999;
Mueller et al., 2014; Bortlein et al., 2018) (Figure 4B).
In support of its importance in TCR signaling, NSM2-deficient
cells proved to be highly dependent on costimulation and unable
to mobilize Ca2+ at low (most likely physiologically more
relevant) antigen doses (Bortlein et al., 2018). Acting at the
cytosolic leaflet of the plasma membrane, NSM2 could potentially
be involved in modulating the microenvironment of the TCR
by possibly facilitating exposure of the CD3β chain, formation
of TCR microclusters, displacement of cholesterol from the
TCRβ chain, or Lck recruitment (Gagnon et al., 2012; Kapoor-
Kaushik et al., 2016; Swamy et al., 2016; Pageon et al., 2016).
However, neither formation of CD3 clusters nor activation of
Lck was found to be affected in Jurkat cells deficient for NSM2,
whose CD3-dependent activation occurred downstream of Lck,
indicating that NSM2 might not be required for initiation of
TCR signaling but rather its sustainment (Bortlein et al., 2018).
This involves TCR microcluster trafficking, endocytosis, and
directional exocytosis at the peripheral IS (Fooksman et al.,
2010; Hashimoto-Tane et al., 2011). Moreover, production of
TCR-containing vesicles and their release into the synaptic cleft
have been found to enhance T-cell activation (Choudhuri et al.,
2014). Though both NSM2 and ASM are known to regulate
both cytoskeletal activity and endo/exocytosis (Draeger and
Babiychuk, 2013; Schoenauer et al., 2019) (see also below), their
involvement in these particular features of the mature IS has
not been revealed as yet. In contrast, NSM-dependent formation
and polarized release of exosomes from T cells toward the APC
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FIGURE 4 | Role of sphingomyelinase activity in IS formation and T-cell activation. (A) ASM activation through death receptor signaling abrogated Ca2+ mobilization,
NFAT activation, and IL-2 synthesis in costimulated or PMA/ionomycin-activated primary or Jurkat T cells (Lepple-Wienhues et al., 1999; Church et al., 2005). (B) In
CD3/CD28 costimulated T cells, NSM2 activity is spatiotemporally tightly controlled under physiological conditions to promote actin cytoskeletal rearrangements
required for IS formation (spreading response) and activity (as indicated by kinetics and magnitude of accumulating p-tyrosine protein species and proliferation).
NSM2 hyperactivation in response to MV exposure causes loss of actin remodeling, enzyme and ceramide confinement to the lamellopodium, and impairment of IS
activity, while NSM2 deficiency is associated with exaggerated cytoskeletal remodeling and early T-cell activation (Mueller et al., 2014). (C) NSM2 activation in
response to CD3 ligation takes part in early TCR signaling. Though capable of initiating a first wave of TCR signaling, NSM2-deficient cells are unable to recruit a
polarity complex (in T cells confirmed for PKCζ and Cdc42, not yet for Par1b, 3, and 6) and subsequently, the actin and microtubular system required for signal
amplification and sustainment. NSM2 activity in TCR signaling is particularly relevant at low antigen doses, and in its absence, T-cell activation is highly dependent on
signaling provided through costimulation. Whether or not ASM is also activated in costimulation is not entirely resolved as yet (Bai et al., 2015; Bortlein et al., 2018).
were described, revealing that this enzyme indeed contributes to
communication at the level of the IS (Mittelbrunn et al., 2011).
Sustainment of TCR signaling relies on cytoskeletal
reorganization and rapid polarization of organelles promoting
the activity of the IS such as the microtubule organizing center
(MTOC), Golgi, and mitochondria (Martin-Cofreces et al., 2008;
Martin-Cofreces et al., 2014). In line with the key role of NSM2
in this process, NSM2-deficient cells, though capable of signal
initiation, were unable to sustain Lck tyr398 phosphorylation
and largely failed to polarize CD3 molecules and relocalize
the MTOC in response to TCR ligation (Figure 4C). As
reported previously in non-T cells (Krishnamurthy et al., 2007;
Bieberich, 2011), NSM2 promoted membrane recruitment and
activation of the atypical PKCζ, which proved to be crucial to
support MTOC IS polarization. Exogenously applied ceramide
efficiently rescued PKCζ membrane recruitment and MTOC
polarization, indicating that formation of ceramide-enriched
domains at the inner leaflet required for PKCζ activation was
ablated in NSM2-deficient T cells. In line with previously
reported microtubular stabilization due to either NSM2 or
ASM activity as well as physical interaction of ceramide and
tubuli, NSM2 deficiency resulted in microtubular destabilization
also in T cells (He et al., 2012, 2014; Bortlein et al., 2018;
Kong et al., 2018) (Figure 4C).
Though there is a clear role for NSM2 in TCR signaling, it
is dispensable at high antigen dose and strong costimulation
through CD28 (Mueller et al., 2014; Bortlein et al., 2018). The
role of ASM in regulation of T-cell functions is multifaceted
as it is reported to modulate TCR signaling via engagement
of inhibitory (TNFR) and costimulatory (CD28) receptors.
CD28 signaling pathways in costimulated T cells have been
extensively refereed and will not be reiterated herein. We
rather focus on the potential role of ASM activation seen
upon engagement of CD28 for T-cell activation (Boucher et al.,
1995; Collenburg et al., 2016; Bortlein et al., 2018). ASM
overexpression in Jurkat cells substituted for CD28 engagement
with regard to NF-κB activation, suggesting that ASM activation
and extrafacial ceramide release might be favorable for T-cell
activation (Boucher et al., 1995). This was supported by studies
revealing attenuated CD8+ cell proliferation and activation in a
graft-versus-host model in ASM-deficient mice and interference
of pharmacological and genetic ASM activation with activation
and functional differentiation of human naïve CD4+ T cells
stimulated with α-CD3/CD28 coated beads in vitro (Rotolo et al.,
2009; Bai et al., 2015). In contrast, costimulation of primary
T cells on a planar surface was associated with retention of
NSM2 activity, but not of ASM. This suggested the ASM activity
might be promoted by ligation of CD28 alone to prevent T-cell
activation and that activation of the enzyme might rather be
silenced upon antigen recognition (Mueller et al., 2014; Bortlein
et al., 2018). Interestingly, uncontrolled inflammatory T helper 1
(Th1) and Th17 responses were observed in ASM-deficient mice
in a pathogen-driven colitis model (Meiners et al., 2019). Taking
into account the differential effect of genetic ASM deficiency on
T-cell subsets in this and another study (Hollmann et al., 2016)
(detailed below), there is an obvious need to ultimately resolve the
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role of ASM in T-cell viability, activation, and expansion before
this pathway can be explored for therapeutical intervention.
As referred to above, ASM activity and extrafacial ceramide
release upon CD95 or TNFR ligation interfered with T-cell
activation, and homeostatic ASM activity dampened their Treg
function, further suggesting a negative rather than supportive
role of this enzyme in T cells (Lepple-Wienhues et al., 1999;
Church et al., 2005). Among other potential mechanisms, cross-
regulation at the level of outer and inner leaflet membrane
microdomains might contribute to ASM-mediated interference
with TCR signaling. Hence, integrity of extrafacial nanodomains
enriched in sphingomyelin was found to play a crucial role
in triggering the phosphatidylinositol-3 kinase/Akt signaling
pathway at the inner membrane leaflet by facilitating Akt
recruitment and activation upon phosphatidylinositol-3,4,5-
triphosphate accumulation (Lasserre et al., 2008). Remarkably,
exogenously added sphingomyelinase prevented formation of
inner leaflet nanodomains and, thereby, Akt activation, which is a
central effector in costimulation. Moreover, ASM activation may
result in collapse and paralysis of the T-cell actin cytoskeleton as
revealed by MV surface contact (Gassert et al., 2009). In contrast
to stimulated conventional T cells, the steady-state activity
of ASM appears to negatively regulate the Treg compartment
because this T-cell subset was represented at higher frequencies in
ASM-deficient mice at the expense of conventional CD4+ T-cell
(Tconv) frequencies (Hollmann et al., 2016; Zhou et al., 2016).
IMPACT OF SPHINGOMYELINASES ON
T-CELL DIFFERENTIATION AND
EFFECTOR FUNCTION
The role of ASM in differentiation of the CD4+ Tconv subset
following clonal expansion is as yet unclear. While CD4+
T cells of ASM-deficient mice effectively differentiated into
Th1 and Th17 cells with comparable kinetics and magnitude
as their wild-type kins, ASM deficiency abrogated in vitro
differentiation of human CD4+ T cells into Th17 cells (Tischner
et al., 2011; Bai et al., 2015). Sphingomyelinase activity-
dependent regulation of Tconv effector functions was clearly
identified at the level of cytokine release. Mechanistically,
this may relate to the documented impact of both ASM
and NSM2 on the vesicular secretory pathway alluded to
above (Stoffel et al., 2016), with specificities for individual
cytokines/effectors being noted. Revealing the importance for
ASM in IL-2 release, this cytokine was produced to lower
amounts by ASM-deficient splenocytes and CD4+ T cells
(Stoffel et al., 1998; Tischner et al., 2011), and this should
have an obvious effect on the activity of other T-cell subsets
depending on this cytokine. In fact, ASM-deficient effector
memory T cells reacquired resistance against glucocorticoid-
induced cell death upon IL-2 addition, and reduced levels of
IL-2 secretion by ASM-deficient CD4+ T cells contributed to
impairment of primary CD8+ T-cell responses in mice infected
with lymphocytic choriomeningitis virus (LCMV) (Herz et al.,
2009; Tischner et al., 2011). In this model, viral clearance was
less efficient in the absence of ASM with impairment of IFN-
γ production and full degranulation of CD8+ T cells being
strongly affected. While ASM might control IFN-γ release
[as that of IL-17 in human T cells (Bai et al., 2015)] in
this setting via its impact on the secretory pathway, defective
degranulation was attributed to lack of membrane tension
as required for efficient expulsion in the absence of ASM
(Herz et al., 2009).
A role for NSM2 in the development and differentiation of
the T-cell compartment has not yet been established. NSM2
catalyzes formation of exosomes which, as efficient subcellular
vectors, would be expected to take part in regulating release
of effector molecules from T cells (Trajkovic et al., 2008).
Thus, NSM2-dependent unidirectional exosomal transfer of
micro-RNAs from T cells to APCs was reported (Mittelbrunn
et al., 2011), and this mechanism may also apply to transfer
of coinhibitory micro-RNAs, which are released from Treg ,
thereby contributing to Treg-mediated suppression (Okoye et al.,
2014). Again not yet directly proven, NSM2 may take part
in Treg TCR activation upon engagement of auto-antigens
and thereby contribute to survival and replenishment of
the Treg pool. As pointed out above, ASM activity has a
significant impact on the Treg compartment that is increased
upon both genetic and pharmacological inhibition of the
enzyme (Hollmann et al., 2016; Zhou et al., 2016). Basal
ASM activity and levels of accumulated ceramides measured
in Treg cells exceed those of Tconv cells, possibly reflecting
the role of ASM in Treg survival, which is highly dependent
on CD28 signaling (Hollmann et al., 2016). Moreover, Akt
ser473 phosphorylation and Rictor levels were reduced in ASM-
deficient Treg , indicating that the enzyme controls metabolic
activity in these cells (Zhou et al., 2016). In addition to
their frequency, ASM also negatively regulates Treg function
because their suppressive activity and CTLA-4 turnover is
enhanced in the absence of Asm. Importantly, enhancement of
Treg activity upon ASM depletion was reflected by reduction
of MV-specific CD8+ T cells in spleens, lymph nodes,
and brains of experimentally infected animals and, thereby,
enhancement of viral central nervous system (CNS) infection
(Hollmann et al., 2016). ASM targets downregulating Treg
activity are undefined as is the role of ASM catalyzed
ceramide release in this process. Curiously, ceramide levels were
found even increased in ASM-deficient T cells, including Treg
(Horinouchi et al., 1995; Hollmann et al., 2016; Schuchman
and Desnick, 2017), indicating that compensatory activities
act to modulate this pool. A recent study provided clear
evidence that ceramide accumulation is particularly important
in Treg metabolism, and function is driven by Foxp3 activity
(Apostolidis et al., 2016; Kasper et al., 2016). The latter suppressed
sphingomyelin synthase 1 (SMS1) expression and, thereby,
conversion of ceramide into sphingomyelin. Accumulated
ceramides promoted PP2A activation by trapping its inhibitory
factor SET. Thereby, mTORC1 activity was downregulated
while Foxp3 expression was stabilized in Treg , and their
suppressive activity was enhanced. ASM-catalyzed ceramide
release obviously had the opposite effect on Treg function
(Hollmann et al., 2016; Zhou et al., 2016), and kinetics,
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magnitude, or compartmentalization of enzyme activity and/or
ceramide release may contribute.
SPHINGOMYELINASES TAKE PART IN
BUT ARE NOT THE SOLE PLAYERS IN
MODULATING T-CELL BIOLOGY AT THE
LEVEL OF SPHINGOLIPID METABOLISM
As introduced earlier (Figure 1), biosynthesis and metabolization
of sphingolipids is a highly dynamic process. Though this review
has focused on the activity of sphingomyelinases and subsequent
ceramide production, virtually all enzymes acting to define
membrane sphingolipid composition are therefore important in
cellular responses, also T cells and selected examples will be
briefly considered here.
Thus, ceramide species generated by the activity of ER-
resident ceramide synthases (CerS1–CerS6) differing in acyl
chain length specificity (C14 to C26). These are expressed in
a tissue-specific manner, with CerS2 and CerS4 being most
abundant in lymphatic tissues and in leukocytes, thereby defining
the accumulation of intermediate (C18–C20) or long or very
long chain (C20–C26) ceramides as building blocks (Levy and
Futerman, 2010; Stiban et al., 2010). Studies mainly conducted
in CerS2 mice revealed the importance of especially very long
chain sphingolipids (VLC-SLs) in immune cell functions. This
may occur at the level of membrane microdomain composition
as shown in liver cells, and neutrophil receptor sorting, signaling,
or stability of receptors in lipid rafts was affected in the absence
of CerS2 (Park et al., 2013; Barthelmes et al., 2015). In the
T-cell compartment, CerS2 has been found to facilitate thymocyte
egress by its ability to regulate S1P gradients, and as key to
production of VLC-SLs for development and homeostasis of
invariant NKT cells, for which they serve as activating ligands
(Rieck et al., 2017; Saroha et al., 2017).
As already alluded to above, glycosphingolipids are major
constituents of lipid rafts, the role of which in T-cell development,
activation, and signal initiation has been amply documented
(for a review, see Wu et al., 2016; Nakayama et al., 2018) and
will not be reiterated here. Of note, T-cell subsets substantially
differ with regard to their membrane composition of membrane
gangliosides. This proved to be critical for their function and
has been suggested to link to organization of specific membrane
microdomains by the respective gangliosides (Inokuchi et al.,
2013). The importance of another ceramide derivative, C1P,
generated through the activity of the ceramide kinase, for T cells
is less well investigated. In contrast to what has been reported
for ceramide accumulation, increased levels of C1P were found
to activate Ca2+ mobilization via store-operated channeling in
Jurkat cells (Church et al., 2005; Colina et al., 2005).
Ceramide accumulation due to sphingomyelin breakdown
is counter-regulated by the activity of two enzyme species,
ceramidases and sphingomyelin synthases, giving rise to
sphingosine or sphingomyelin, respectively (Figure 1). In line
with its ability to metabolize ceramide, genetic depletion of
acid ceramidase increased overall ceramide levels, while its
overexpression promoted cell growth as analyzed in non-
lymphoid cancer cells (Saad et al., 2007; Brodlie et al., 2010). More
recently, exogenous application of acid ceramidase was found to
cause Akt kinase activation in Jurkat cells, and, however, affected
their expansion. The latter was suggested to relate to the inability
of the added ceramidase to promote activation of sphingosine
kinase and, thereby, production of S1P in this system (Baduva
et al., 2019). The ability of this particular bioactive sphingolipid to
substantially regulate survival, trafficking, and activity of immune
cells including T cells is well established, and with FTY720, a drug
targeting S1P activity is in clinical use. Though it is therefore
of critical importance to fully appreciate the relevance of the
sphingolipid metabolism on T cells, it is far beyond the scope of
this review to extend on this topic (for excellent reviews, see Pyne
and Pyne, 2010; Stepanovska and Huwiler, 2019).
SMS1 and 2 both localize to the Golgi compartment, while
SMS2 is also found at the plasma membrane. As being crucial for
de novo sphingomyelin synthesis, they regulate availability of this
sphingolipid (and thereby glycosphingolipids) for organization
and integrity of lipid rafts. Therefore, their activity is also of
crucial importance in the regulation of T-cell biology, and this
has been highlighted in studies revealing that TCR signaling,
migration, and apoptosis are highly sensitive to the absence of
SMS1 (Jin et al., 2008; Lafont et al., 2010; Asano et al., 2012).
Because its catalytic site locates to the extrafacial leaflet of the
plasma membrane, SMS2 can directly oppose ASM activity and,
thereby, ceramide accumulation by regenerating sphingomyelin
(Milhas et al., 2010a). The role of SMS2 in T-cell development
and activation has, however, not yet been investigated. Curiously,
SMS2 rather than SMS1 was found to be involved in HIV-1 env-
mediated membrane fusion with T cells, and this activity was
attributed to the SMS2 protein itself rather than to its enzymatic
activity (Hayashi et al., 2014).
OUTLOOK
Common to that of other cell types and compartments, the
spatiotemporal resolution of the sphingolipid metabolism will
crucially advance our understanding of the impact of this system
on T-cell activation, trafficking, differentiation and effector
functions, and, thereby, in protection or pathophysiology. At a
cellular level, this, for instance, applies to the enzyme NSM2,
which, in non-T cells, appears to shuttle between the plasma
membrane, endo-lysosomal, Golgi, and nuclear membranes
(Albi et al., 2008; Cascianelli et al., 2008; Clarke et al., 2008;
Trajkovic et al., 2008; Milhas et al., 2010b; Airola and Hannun,
2013), where conceivably the sphingomyelin breakdown may
differ in kinetics, efficiency, and physiological responses. The
advent of bio-orthogonally mono-, bi-, or tri-functionalized
sphingolipids in conjunction with targeted enzymes has enabled
us and others to investigate trafficking and compartment-
specific metabolization of sphingolipids (Haberkant et al., 2013,
2016; Hoglinger et al., 2014, 2017; Collenburg et al., 2016;
Walter et al., 2016, 2017; Feng et al., 2018; Laguerre and
Schultz, 2018), and if further advanced, this toolbox will allow
to study the impact of compartment-specific enzyme activity
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and lipid localization on signaling and the metabolic fate of
T cells. This also applies to detailed studies on membrane
topology of sphingolipid metabolites being generated and/or
accumulating at cytosolic or anticytosolic membrane leaflets
and organizing membrane microdomains there, which will be a
challenging task. Reagents and microscopical techniques allowing
to resolve lipid association with membrane leaflets ideally
also allowing for codetection and copurification of proteins
continue to be developed (Heilemann et al., 2009; Collenburg
et al., 2016; Burgert et al., 2017). In combination with mass
spectrometry performed on protein complexes crosslinking to
functionalized sphingolipids after photoactivation (Hoglinger
et al., 2014, 2017; Haberkant et al., 2016), detailed analyses on
the organization of functionally active membrane microdomains
such as, for instance, lamellopodia or immune synapses, will
become possible.
Mass spectroscopy-based analytical approaches have
substantially increased the sensitivity to detect and quantify
sphingolipids and, when coupled to imaging, enabled spatial
resolution of sphingolipid classes accumulating in tissue
specimens, for the time being, at the expense of sensitivity
(reviewed in Luberto et al., 2019). If further advanced, this
technology will be very instrumental in relating sphingolipid
patterning to the architecture of lymphoid tissue and, ideally,
cellular compartments therein. At an organismic level, inbred
mouse strain deficient for or overexpressing sphingolipid
metabolizing enzymes have provided important insight into the
importance of this system also in T-cell biology (see above).
Ubiquitous disruption of enzyme activity was often associated
with the development of lipid storage or other severe diseases
in mice, thereby precluding long-term analyses or—except
for adoptive transfer approaches—hampered assignment of
immunological alterations to a specific compartment in vivo.
In conjunction with the progress made in evaluating the
sphingolipid metabolism in T cells at a subcellular, cellular and
tissue level, the recent advent of novel mouse strains allowing
for cell-specific inducible expression or ablation of sphingolipid-
modifying enzymes will doubtlessly enable the understanding of
this system for T-cell biology and delineate targets and strategies
for specific intervention.
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